These resources can be adapted to your city or jurisdiction’s needs.

Please contact Dr. Monica Gandhi MD, MPH, Medical Director of Ward 86 (monica.gandhi@ucsf.edu), if you have questions about any of these materials.

• Guidance on initiation and management of patients initiating and continuing CAB LA and LEN LA. Ward 86 Long Acting Pre-Exposure Prophylaxis (PrEP) Guidelines, November 2025.

• Guidance on long-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) and lenacapavir (LEN) for their patients, even for those with adherence challenges and viremia. Ward 86 Long-Acting Antiretroviral Treatment (ART) Guidelines, November 2025.